BioStem Technologies, Inc.
BSEM
$3.85
-$0.11-2.68%
OTC PK
| 03/31/2026 | 09/30/2025 | 06/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | 303.11% | 459.40% | 589.29% | 376.38% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | 303.11% | 459.40% | 589.29% | 376.38% |
| Cost of Revenue | -- | -42.18% | 34.10% | 34.10% | 263.74% |
| Gross Profit | -- | 381.87% | 540.08% | 694.61% | 383.41% |
| SG&A Expenses | -- | 702.39% | 717.01% | 941.88% | 317.36% |
| Depreciation & Amortization | -- | 10.03% | 7.34% | 7.34% | 0.40% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | 482.26% | 571.28% | 743.50% | 315.45% |
| Operating Income | -- | -25.81% | 116.14% | 116.14% | 3,943.31% |
| Income Before Tax | -- | -21.12% | 162.81% | 162.81% | 1,268.28% |
| Income Tax Expenses | -- | -173.39% | -175.88% | -192.32% | -191.44% |
| Earnings from Continuing Operations | -- | 44.07% | 387.90% | 398.82% | 939.21% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -- | 44.07% | 387.90% | 398.82% | 939.21% |
| EBIT | -- | -25.81% | 116.14% | 116.14% | 3,943.31% |
| EBITDA | -- | -66.47% | 35.76% | 35.76% | 3,945.19% |
| EPS Basic | -- | 43.97% | 435.05% | 446.91% | 737.58% |
| Normalized Basic EPS | -- | -66.19% | 46.44% | 46.44% | 1,128.22% |
| EPS Diluted | -- | 29.67% | 541.21% | 553.21% | 504.70% |
| Normalized Diluted EPS | -- | -70.22% | 50.07% | 50.07% | 673.99% |
| Average Basic Shares Outstanding | -- | 3.94% | 8.04% | 8.04% | 12.97% |
| Average Diluted Shares Outstanding | -- | 16.99% | 26.75% | 26.75% | 52.94% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |